Search research articles
Contact Us
Filters
Showing results (81-90 of 118) with videos related to
Page
of 12
Sort By:
Cellular Immunology
|
June 23, 2016
MicroRNA-150 negatively regulates the function of CD4(+) T cells through AKT3/Bim signaling pathway
Wei Sang, Cai Sun, Cong Zhang, et al.
Bone Marrow Transplantation
|
May 11, 2020
Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment
Hujun Li, Lingling Yin, Ying Wang, et al.
Transplantation and Cellular Therapy
|
December 3, 2021
Absolute Lymphocyte Count Prior to Lymphodepletion Impacts Outcomes in Multiple Myeloma Patients Treated with Chimeric Antigen Receptor T Cells
Yang Liu, Wei Chen, Mingxiao Yu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 2, 2019
Coagulation Disorders after Chimeric Antigen Receptor T Cell Therapy: Analysis of 100 Patients with Relapsed and Refractory Hematologic Malignancies
Ying Wang, Kunming Qi, Hai Cheng, et al.
International Immunopharmacology
|
December 11, 2017
Increased ADAM10 expression in patients with immune thrombocytopenia
Jianlin Qiao, Qi Luo, Na Liu, et al.
Hematology (Amsterdam, Netherlands)
|
January 22, 2024
The prognostic significance of POD24 in peripheral T-cell lymphoma
Huimin Chen, Ruixue Ma, Qianqian Zhang, et al.
Oncology Reports
|
April 23, 2020
TIRC7 inhibits Th1 cells by upregulating the expression of CTLA‑4 and STAT3 in mice with acute graft‑versus‑host disease
Feng Zhu, Tingting Qiu, Shengyun Zhu, et al.
Journal of Hematology & Oncology
|
October 29, 2024
Long-term survival with donor CD19 CAR-T cell treatment for relapsed patients after allogeneic hematopietic stem cell transplantation
Cheng Zhang, Xiaoqi Wang, Hai Yi, et al.
International Journal of Laboratory Hematology
|
October 28, 2020
Kinetics of immune reconstitution after anti-CD19 chimeric antigen receptor T cell therapy in relapsed or refractory acute lymphoblastic leukemia patients
Ying Wang, Hujun Li, Xuguang Song, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
November 11, 2022
Factors associated with infection events after chimeric antigen receptor T-cell therapy for relapsed or refractory multiple myeloma
Dian Zhou, Ying Wang, Hai Cheng, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 118) with videos related to
Sort By:
Page
of 12
Cellular Immunology
|
June 23, 2016
MicroRNA-150 negatively regulates the function of CD4(+) T cells through AKT3/Bim signaling pathway
Wei Sang, Cai Sun, Cong Zhang, et al.
Bone Marrow Transplantation
|
May 11, 2020
Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment
Hujun Li, Lingling Yin, Ying Wang, et al.
Transplantation and Cellular Therapy
|
December 3, 2021
Absolute Lymphocyte Count Prior to Lymphodepletion Impacts Outcomes in Multiple Myeloma Patients Treated with Chimeric Antigen Receptor T Cells
Yang Liu, Wei Chen, Mingxiao Yu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 2, 2019
Coagulation Disorders after Chimeric Antigen Receptor T Cell Therapy: Analysis of 100 Patients with Relapsed and Refractory Hematologic Malignancies
Ying Wang, Kunming Qi, Hai Cheng, et al.
International Immunopharmacology
|
December 11, 2017
Increased ADAM10 expression in patients with immune thrombocytopenia
Jianlin Qiao, Qi Luo, Na Liu, et al.
Hematology (Amsterdam, Netherlands)
|
January 22, 2024
The prognostic significance of POD24 in peripheral T-cell lymphoma
Huimin Chen, Ruixue Ma, Qianqian Zhang, et al.
Oncology Reports
|
April 23, 2020
TIRC7 inhibits Th1 cells by upregulating the expression of CTLA‑4 and STAT3 in mice with acute graft‑versus‑host disease
Feng Zhu, Tingting Qiu, Shengyun Zhu, et al.
Journal of Hematology & Oncology
|
October 29, 2024
Long-term survival with donor CD19 CAR-T cell treatment for relapsed patients after allogeneic hematopietic stem cell transplantation
Cheng Zhang, Xiaoqi Wang, Hai Yi, et al.
International Journal of Laboratory Hematology
|
October 28, 2020
Kinetics of immune reconstitution after anti-CD19 chimeric antigen receptor T cell therapy in relapsed or refractory acute lymphoblastic leukemia patients
Ying Wang, Hujun Li, Xuguang Song, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
November 11, 2022
Factors associated with infection events after chimeric antigen receptor T-cell therapy for relapsed or refractory multiple myeloma
Dian Zhou, Ying Wang, Hai Cheng, et al.
Page
of 12